Page last updated: 2024-08-24

ranolazine and Tachycardia, Ventricular

ranolazine has been researched along with Tachycardia, Ventricular in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (15.15)	29.6817
2010's	22 (66.67)	24.3611
2020's	6 (18.18)	2.80

Authors

Authors	Studies
Arafune, T; Dobrev, D; Honjo, H; Kodama, I; Makita, N; Nattel, S; Niwa, R; Sakuma, I; Takanari, H; Tomii, N; Tsuji, Y; Tsuneyama, K; Yamazaki, M	1
Andrade, JG; Deyell, MW	1
Aktas, M; Beck, CA; Bernabei, MA; Daubert, J; Farooq, S; Goldenberg, I; Huang, DT; Mazur, A; McNitt, S; Mitchell, BL; Raitt, M; Rashtian, MR; Vloka, M; Winters, S; Yavin, H; Younis, A; Zareba, W	1
Chan, CS; Chen, SA; Chen, YC; Chen, YJ; Higa, S; Lin, FJ; Lin, YK; Liu, CM; Lu, YY	1
Chang, GJ; Chang, PC; Chou, CC; Chu, Y; Lee, HL; Liu, HT; Wen, MS; Wo, HT; Yen, TH	1
Al-Khatib, SM; Allen LaPointe, NM; Curtis, LH; Hammill, BG; Mi, X; Pokorney, SD	1
Bontempi, L; Cerini, M; Curnis, A; Giacopelli, D; Inama, L; Raweh, A; Salghetti, F; Sciatti, E; Vassanelli, F; Villa, C; Vizzardi, E	1
Albert, CM	1
Aktas, MK; Alexis, JD; Ayala-Parades, F; Baranchuk, A; Beck, CA; Brown, MW; Daubert, JP; Dubuc, M; Feng, C; Haigney, M; Huang, DT; Mazur, A; McNitt, S; McPherson, CA; Mitchell, LB; Moss, AJ; Natale, A; Oakes, D; Piccini, JP; Pyykkonen, K; Raitt, M; Rashtian, MY; Schuger, C; Winters, S; Worley, SJ; Zareba, W; Ziv, O	1
Aidonidis, I; Dipla, K; Hatziefthimiou, A; Moschovidis, V; Simopoulos, V; Stamatiou, R; Stravela, S	1
Aljassim, O; Bonadei, I; Bontempi, L; Curnis, A; D'Aloia, A; Raweh, A; Salghetti, F; Vizzardi, E	1
Dale, RA; Haigney, MC; Krantz, MJ; Schuller, JL; Yeung, E	1
Belardinelli, L; Kanas, AF; Morrow, DA; Nearing, BD; Nieminen, T; Pagotto, VP; Pegler, JR; Scirica, BM; Sobrado, MF; Tavares, C; Umez-Eronini, AA; Verrier, RL	1
Kaliebe, J; Murdock, DK; Overton, N	1
Belardinelli, L; January, CT; Li, H; Rajamani, S; Shryock, JC; Wu, L	1
Belardinelli, L; Bhandari, A; Dhalla, AK; Dow, J; Kloner, RA; Shryock, JC; Wang, WQ	1
Kaliebe, JW; Murdock, DK	1
Freudenberger, R; Levin, V; Martinez, MW; Nanda, S	1
Bhandari, A; Dow, JS; Kloner, RA	2
Patton, KK	1
Belardinelli, L; Braunwald, E; Hedgepeth, CM; Karwatowska-Prokopczuk, E; Morrow, DA; Qin, J; Scirica, BM; Spinar, J; Verheugt, FW; Wang, W	1
Madias, JE	1
Ayalloore, SG; LeLorier, P	1
Belardinelli, L; Budas, GR; Fan, P; Hirakawa, R; Jiang, Z; Kornyeyev, D; Rajamani, S; Shryock, JC; Viatchenko-Karpinski, S; Wu, Y; Yao, L	1
Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP	1
Atack, TC; Hall, L; Lowe, JS; Roden, DM; Stroud, DM; Yang, T	1
Andrikopoulos, G; Tzeis, S	1
Belardinelli, L; Kanas, AF; Nearing, BD; Pagotto, VP; Sobrado, MF; Verrier, RL; Zeng, D	1
Aiba, T; Begley, MJ; Boström, P; Cantley, LC; Das, S; del Monte, F; Ellinor, PT; Graham, EL; Hessler, K; Knight, AC; Morissette, MR; Ottaviano, FG; Quintero, PA; Rosenberg, M; Rosenzweig, A; Tomaselli, GF; Xiao, C	1
Greer-Short, A; Poelzing, S; Radwański, PB	1
Belardinelli, L; Breithardt, G; Eckardt, L; Frommeyer, G; Kaese, S; Kaiser, D; Milberg, P; Osada, N; Rajamani, S; Uphaus, T	1
Antzelevitch, C; Belardinelli, L; Glass, A; Goodrow, RJ; Sicouri, S; Timothy, KW; Zygmunt, AC	1

Trials

4 trial(s) available for ranolazine and Tachycardia, Ventricular

Article	Year
Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAID Trial. JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:6 Topics: Aged; Defibrillators, Implantable; Humans; Ranolazine; Tachycardia, Ventricular	2022
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial. Journal of the American College of Cardiology, 2018, 08-07, Volume: 72, Issue:6 Topics: Aged; Cardiovascular Agents; Defibrillators, Implantable; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Ranolazine; Risk Factors; Tachycardia, Ventricular; Ventricular Fibrillation	2018
Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo. The American journal of cardiology, 2014, Jul-01, Volume: 114, Issue:1 Topics: Acetanilides; Acute Coronary Syndrome; Aged; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Female; Heart Conduction System; Humans; Male; Middle Aged; Piperazines; Placebos; Predictive Value of Tests; Ranolazine; Risk Factors; Tachycardia, Ventricular; Treatment Outcome	2014
Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thr Circulation, 2010, Aug-03, Volume: 122, Issue:5 Topics: Acetanilides; Acute Coronary Syndrome; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Follow-Up Studies; Humans; Incidence; Myocardial Infarction; Piperazines; Placebos; Prognosis; Proportional Hazards Models; Ranolazine; Risk Factors; Tachycardia, Ventricular; Thrombolytic Therapy; Ventricular Premature Complexes	2010

Other Studies

29 other study(ies) available for ranolazine and Tachycardia, Ventricular

Article	Year
Rotors anchored by refractory islands drive torsades de pointes in an experimental model of electrical storm. Heart rhythm, 2022, Volume: 19, Issue:2 Topics: Action Potentials; Animals; Atrioventricular Block; Defibrillators, Implantable; Disease Models, Animal; Long QT Syndrome; Rabbits; Ranolazine; Tachycardia, Ventricular; Torsades de Pointes	2022
A Role for Ranolazine in the Treatment of Ventricular Arrhythmias? JACC. Clinical electrophysiology, 2022, Volume: 8, Issue:6 Topics: Arrhythmias, Cardiac; Humans; Ranolazine; Tachycardia, Ventricular	2022
Modulation of post-pacing action potential duration and contractile responses on ventricular arrhythmogenesis in chloroquine-induced long QT syndrome. European journal of pharmacology, 2023, Feb-15, Volume: 941 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Azithromycin; Long QT Syndrome; Rabbits; Ranolazine; Sodium; Tachycardia, Ventricular	2023
Mechanisms of ranolazine pretreatment in preventing ventricular tachyarrhythmias in diabetic db/db mice with acute regional ischemia-reperfusion injury. Scientific reports, 2020, 11-18, Volume: 10, Issue:1 Topics: Action Potentials; Animals; Calcium; Calcium-Binding Proteins; Cardiovascular Agents; Diabetes Mellitus, Experimental; Female; Heart Rate; Mice; Myocardial Reperfusion Injury; Ranolazine; Tachycardia, Ventricular	2020
Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia. The American journal of cardiology, 2017, 05-01, Volume: 119, Issue:9 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Databases, Factual; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Humans; Logistic Models; Male; Medicare Part D; Mexiletine; Ranolazine; Sodium Channel Blockers; Sotalol; Tachycardia, Ventricular; United States	2017
Ranolazine therapy in drug-refractory ventricular arrhythmias. Journal of cardiovascular medicine (Hagerstown, Md.), 2017, Volume: 18, Issue:7 Topics: Aged; Anti-Arrhythmia Agents; Defibrillators, Implantable; Disease Progression; Drug Resistance; Electric Countershock; Female; Heart Failure; Humans; Male; Middle Aged; Ranolazine; Recurrence; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Fibrillation	2017
Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time? Journal of the American College of Cardiology, 2018, 08-07, Volume: 72, Issue:6 Topics: Defibrillators, Implantable; Electric Countershock; Humans; Ranolazine; Tachycardia, Ventricular	2018
Dose-Dependent Effects of Ranolazine on Reentrant Ventricular Arrhythmias Induced After Subacute Myocardial Infarction in Rabbits. Journal of cardiovascular pharmacology and therapeutics, 2020, Volume: 25, Issue:1 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Rate; Male; Myocardial Infarction; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation	2020
Efficacy of ranolazine in a patient with idiopathic dilated cardiomyopathy and electrical storm. Drug discoveries & therapeutics, 2013, Volume: 7, Issue:1 Topics: Acetanilides; Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiography; Heart Rate; Humans; Male; Piperazines; Ranolazine; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left	2013
Ranolazine for the suppression of ventricular arrhythmia: a case series. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2014, Volume: 19, Issue:4 Topics: Acetanilides; Adult; Aged; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes	2014
Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report. Pacing and clinical electrophysiology : PACE, 2008, Volume: 31, Issue:6 Topics: Acetanilides; Aged; Cardiomyopathies; Enzyme Inhibitors; Humans; Male; Myocardial Ischemia; Piperazines; Ranolazine; Tachycardia, Ventricular; Treatment Outcome	2008
Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:3 Topics: 4-Aminopyridine; Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Barium Compounds; Cell Line; Chlorides; Enzyme Inhibitors; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Heart Conduction System; Humans; Kidney; Patch-Clamp Techniques; Piperazines; Piperidines; Potassium Channel Blockers; Pyridines; Rabbits; Ranolazine; Sodium; Sodium Channel Blockers; Sodium Channels; Tachycardia, Ventricular; Tetrodotoxin; Torsades de Pointes	2009
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:5 Topics: Acetanilides; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Infusions, Intravenous; Injections, Intravenous; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation	2009
Suppression of non-sustained ventricular tachycardia with ranolazine: a case report. WMJ : official publication of the State Medical Society of Wisconsin, 2009, Volume: 108, Issue:7 Topics: Acetanilides; Aged; Electrocardiography, Ambulatory; Enzyme Inhibitors; Female; Humans; Piperazines; Ranolazine; Tachycardia, Ventricular	2009
Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy. Pacing and clinical electrophysiology : PACE, 2010, Volume: 33, Issue:12 Topics: Acetanilides; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Coronary Artery Bypass; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dyspnea; Enzyme Inhibitors; Humans; Male; Middle Aged; Piperazines; Ranolazine; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes	2010
The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channel. Cardiovascular therapeutics, 2011, Volume: 29, Issue:4 Topics: Acetanilides; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Female; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Tachycardia, Ventricular	2011
The riddle of nonsustained ventricular tachycardia and sudden cardiac death: are we approaching a solution? Circulation, 2010, Aug-03, Volume: 122, Issue:5 Topics: Acetanilides; Death, Sudden, Cardiac; Defibrillators, Implantable; Enzyme Inhibitors; Humans; Piperazines; Predictive Value of Tests; Ranolazine; Risk Factors; Tachycardia, Ventricular; United States	2010
First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model. Journal of cardiovascular pharmacology and therapeutics, 2011, Volume: 16, Issue:2 Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Enzyme Inhibitors; Female; Infusions, Intravenous; Injections, Intravenous; Lidocaine; Myocardial Reperfusion Injury; Piperazines; Random Allocation; Ranolazine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Sotalol; Statistics, Nonparametric; Tachycardia, Ventricular; Ventricular Fibrillation	2011
Letter by Madias regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST- Circulation, 2011, Apr-12, Volume: 123, Issue:14 Topics: Acetanilides; Acute Coronary Syndrome; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Heart Rate; Humans; Myocardial Infarction; Myocardial Ischemia; Piperazines; Predictive Value of Tests; Ranolazine; Risk Factors; Stroke Volume; Tachycardia, Ventricular; Thrombolytic Therapy	2011
Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Isc Circulation, 2011, Apr-12, Volume: 123, Issue:14 Topics: Acetanilides; Acute Coronary Syndrome; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Heart Rate; Humans; Myocardial Infarction; Myocardial Ischemia; Piperazines; Predictive Value of Tests; Ranolazine; Risk Factors; Stroke Volume; Tachycardia, Ventricular; Thrombolytic Therapy	2011
Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice. American journal of physiology. Cell physiology, 2011, Volume: 301, Issue:3 Topics: Acetanilides; Amino Acid Substitution; Animals; Animals, Newborn; Calcium; Calcium Signaling; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Caspase 3; Cell Death; Cell Survival; Cnidarian Venoms; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Female; Gene Expression; Heart Ventricles; Humans; Mice; Mice, Inbred Strains; Mice, Transgenic; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Peptides; Perfusion; Phosphorylation; Piperazines; Protein Binding; Rabbits; Ranolazine; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Ryanodine Receptor Calcium Release Channel; Sodium; Sodium Channels; Sodium-Calcium Exchanger; Tachycardia, Ventricular; Tetrodotoxin; Veratridine	2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Pacing and clinical electrophysiology : PACE, 2011, Volume: 34, Issue:12 Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Defibrillators, Implantable; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Hypoglycemia; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Ischemia; Piperazines; Ranolazine; Sotalol; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome	2011
Increased late sodium current contributes to long QT-related arrhythmia susceptibility in female mice. Cardiovascular research, 2012, Aug-01, Volume: 95, Issue:3 Topics: Acetanilides; Action Potentials; Animals; Cnidarian Venoms; Disease Models, Animal; Electrocardiography; Female; Genetic Predisposition to Disease; Humans; Long QT Syndrome; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Piperazines; Ranolazine; Risk Factors; Sex Factors; Tachycardia, Ventricular; Time Factors	2012
Antiarrhythmic properties of ranolazine--from bench to bedside. Expert opinion on investigational drugs, 2012, Volume: 21, Issue:11 Topics: Acetanilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as Topic; Humans; Piperazines; Ranolazine; Tachycardia, Ventricular	2012
Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia. Heart rhythm, 2013, Volume: 10, Issue:1 Topics: Acetanilides; Amiodarone; Animals; Atrial Fibrillation; Chromatography, High Pressure Liquid; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Electrocardiography; Hemodynamics; Piperazines; Ranolazine; Swine; Tachycardia, Ventricular	2013
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation, 2012, Oct-30, Volume: 126, Issue:18 Topics: Acetanilides; Animals; Cardiomegaly, Exercise-Induced; Cardiomyopathy, Dilated; Consensus Sequence; Disease Models, Animal; Electrocardiography; Enzyme Induction; Heart Failure; Humans; Hypertension; Immediate-Early Proteins; Ion Channel Gating; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Protein Interaction Mapping; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Ranolazine; Sodium Channel Blockers; Tachycardia, Ventricular; Ventricular Remodeling	2012
Inhibition of Na+ channels ameliorates arrhythmias in a drug-induced model of Andersen-Tawil syndrome. Heart rhythm, 2013, Volume: 10, Issue:2 Topics: Acetanilides; Action Potentials; Andersen Syndrome; Animals; Calcium Channels; Cytosol; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Guinea Pigs; Male; Piperazines; Pyridinium Compounds; Random Allocation; Ranolazine; Sensitivity and Specificity; Sodium Channels; Sodium-Calcium Exchanger; Tachycardia, Ventricular	2013
Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits. Heart rhythm, 2012, Volume: 9, Issue:12 Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Electrocardiography; Female; Heart Conduction System; Heart Ventricles; Piperazines; Rabbits; Ranolazine; Tachycardia, Ventricular	2012
Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. Heart rhythm, 2007, Volume: 4, Issue:5 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetanilides; Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Agonists; Disease Models, Animal; Dogs; Electrocardiography; Endocardium; Enzyme Inhibitors; Heart Ventricles; Long QT Syndrome; Myocytes, Cardiac; Patch-Clamp Techniques; Pericardium; Piperazines; Ranolazine; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Premature Complexes	2007